<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744377</url>
  </required_header>
  <id_info>
    <org_study_id>VKVAmericanEHP30</org_study_id>
    <nct_id>NCT03744377</nct_id>
  </id_info>
  <brief_title>Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis</brief_title>
  <official_title>Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>V.K.V. American Hospital, Istanbul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>V.K.V. American Hospital, Istanbul</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometriosis can affect quality of life, including physical, psychological and social
      aspects. It is important to include quality of life measures in evaluating disease severity
      and response to any given treatment. The 30-item Endometriosis Health Profile (EHP-30) from
      in-depth interviews with patients with endometriosis is currently the most reliable
      questionnaire for the measurement of health-related quality of life in women with
      endometriosis. It includes specific questions addressing the problems faced by patients with
      endometriosis. The aim of the present study is to validate the Turkish version of EPH 30, a
      self reported questionnaiere already used internationally, in order to determine the quality
      of life in women with endometriosis, assess their psychological health and the effectiveness
      of therapies.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of Endometriosis health profile-30 (EHP-30) Turkish version</measure>
    <time_frame>baseline</time_frame>
    <description>internal consistency and construct validity</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Endometriosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>The Endometriosis Health Profile EPH-30</intervention_name>
    <description>Self-reported questionnaires</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women referred to Obstetrics and Gynecological Department for the treatment of
        endometriosis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous surgical and histological diagnosis of endometriosis

        Exclusion Criteria:

          -  Severe underlying comorbidities (gynecological, cardiovascular, respiratory, renal,
             hematological, endocrine, hepatic, gastrointestinal, neurological)

          -  Psychiatric diseases

          -  Refusal or inability to sign the informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mehmet Ceyhan, MD</last_name>
    <phone>+905426239426</phone>
    <email>mceyhan85@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehmet Ceyhan</last_name>
    <email>mceyhan85@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34365</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <last_update_submitted>November 14, 2018</last_update_submitted>
  <last_update_submitted_qc>November 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>V.K.V. American Hospital, Istanbul</investigator_affiliation>
    <investigator_full_name>mehmet ceyhan</investigator_full_name>
    <investigator_title>Obstetrician and gynecologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

